Close

Rating History for Fate Therapeutics (FATE) by Morgan Stanley

More Stocks Rated by Morgan Stanley | Latest Ratings for FATE
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/27/2024 Michael Ulz Maintain Equalweight
(N/A)		 7.00
(3.00)		  
 		   Details